Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Central Nervous System Neoplasms 8Brain Neoplasms 5Astrocytoma 5Medulloblastoma 4Oligodendroglioma 3Glioma 3Glioblastoma 3Spinal Cord Neoplasms 1Optic Nerve Glioma 1Lymphoma, AIDS-Related 1Gliosarcoma 1Cognition Disorders 1

Interventions

Etoposide 2ibritumomab tiuxetan 1Vincristine 1Rituximab 1Radiotherapy 1Radioimmunotherapy 1Procarbazine 1Prednisone 1Methylprednisolone 1Lomustine 1Immunization, Passive 1Drug Therapy 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Biological Therapy 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, AIDS-Related × Lomustine × Clear all
NCT01775475 2022-10-10

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

AIDS Malignancy Consortium

Phase 2 Completed
7 enrolled 14 charts
Lymphoid

Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡